Rare diseases
Investigational molecules
Locations
Knollstrasse, 67061 Ludwigshafen Am Rhein, Germany
The sponsor maintains a comprehensive research portfolio addressing immune-mediated conditions affecting multiple organ systems. Investigation encompasses rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, exploring various therapeutic interventions including JAK inhibitors and TNF-alpha inhibitors. Research extends to inflammatory bowel diseases, specifically Crohn's disease and ulcerative colitis, examining both induction and maintenance treatment strategies.
Studies evaluate disease activity measures, structural damage progression, and patient-reported outcomes across diverse populations, including treatment-naïve patients and those with inadequate responses to conventional therapies. The research incorporates radiographic progression assessment and biomarker analysis to understand therapeutic mechanisms.
AbbVie Deutschland GmbH & Co. KG runs clinical trials in conditions such as Plasma cell myeloma, Colitis ulcerative, Migraine, Acute myeloid leukaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustria
BelgiumBelgium
DenmarkBelgiumBelgium
Bulgaria
France
NorwayAustriaAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
